Author: Truveta

Posted Date:

May 21, 2026

New study reveals major gaps in follow-up care for patients with heart failure

Truveta

May 21, 2026
Truveta and Knit Health announce collaboration to power a new generation of clinical AI

Truveta

May 12, 2026
Truveta unveils Truveta Intelligence, delivering real-time insights from real-world data

Truveta

April 28, 2026
Truveta deepens health system leadership with appointment of Erik Wexler to Board of Directors

Truveta

March 31, 2026
Truveta deepens financial leadership with appointment of Henry Ford Health executive Robin Damschroder, FACHE as Board Chair

Truveta

March 31, 2026
Truveta joins leading experts in calling for public utility framework to govern real-world health data

Truveta

March 5, 2026
FDA cardiovascular indication for semaglutide led to short-term uptake but persistent treatment gaps among high-risk patients, new Truveta study finds

Truveta

February 10, 2026
Truveta deepens regulatory science leadership with appointment of John D. Seeger, PharmD, DrPH, FISPE as Senior Vice President of Evidence Services

Truveta

February 9, 2026
Truveta launches real-time clinical trials solution to accelerate study design, enrollment, and evidence generation

Truveta

January 28, 2026
Truveta deepens oncology and scientific leadership with appointment of Johnathan Lancaster, MD, PhD as President and Chief Scientific Officer

Truveta

January 28, 2026